Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-25 @ 2:42 AM
NCT ID:
NCT00002533
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven head and neck cancer undergoing definitive radiotherapy
PATIENT CHARACTERISTICS:
Age:
* Over 21
Performance status:
* Karnofsky 70-100%
Hematopoietic:
* Not specified
Hepatic:
* SGOT and SGPT less than 2 times normal
* Alkaline phosphatase less than 2 times normal
Renal:
* Not specified
Other:
* No history of hypersensitivity to fluconazole
* HIV negative
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* Not specified
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Other
* At least 2 months since prior antifungal agents
* Not currently receiving phenytoin, hydrochlorothiazide, or warfarin
* If these medications are initiated during study therapy, medication serum levels and electrolytes are monitored for possibility of drug interaction
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
120 Years
Study:
NCT00002533
Study Brief:
Protocol Section:
NCT00002533